Results 21 to 30 of about 436,306 (291)

Carcinosarcoma of the corpus uteri (Malignant Müllerian Mixed Tumor): a case report in Yaoundé (Cameroon) [PDF]

open access: yesThe Pan African Medical Journal, 2013
Carcinosarcoma of the uterus is a rare tumor representing 2-4% of uterine malignancies. Its prognosis is poor with a 5 years survival rate of 10-30%. We report a first documented case of carcinosarcoma occurring in a 62 years old woman who presented with
Zacharie Sando   +5 more
doaj   +2 more sources

The incidence rate of corpus uteri cancer among females in Saudi Arabia: an observational descriptive epidemiological analysis of data from Saudi Cancer Registry 2001–2008

open access: greenInternational Journal of Women's Health, 2014
Ibrahim G Alghamdi,1 Issam I Hussain,1 Mohamed S Alghamdi,2 Mohamed A El-Sheemy1,3 1University of Lincoln, Brayford Pool, Lincoln, UK; 2Ministry of Health, General Directorate of Health Affairs, Al-Baha, Kingdom of Saudi Arabia; 3Research and Development,
Alghamdi IG   +3 more
doaj   +1 more source

Epidemiology of Breast, Corpus Uteri, and Ovarian Cancers in Lebanon With Emphasis on Breast Cancer Incidence Trends and Risk Factors Compared to Regional and Global Rates. [PDF]

open access: yesCancer Control
Objectives This study explores the incidence and trends of breast (Bca), corpus uteri (CUca), and ovarian (Oca) cancer in Lebanon, a Middle Eastern country.
Lakkis NA   +4 more
europepmc   +2 more sources

Corpus Uteri [PDF]

open access: yesDefinitions, 2020
28.2 Uterus myomatosus – 468 28.2.1 Epidemiologie – 468 28.2.2 Pathologie – 469 28.2.3 Pathogenese und Ätiologie – 470 28.2.4 Symptome – 470 28.2.5 Diagnose – 470 28.2.6 Indikationen zur Therapie – 472 28.2.7 Therapieoptionen – 473 28.2.8 Konservative ...
R. Kreienberg
openaire   +2 more sources

Incidence and mortality of corpus uteri cancer in China, 2008-2012. [PDF]

open access: yesChin J Cancer Res, 2019
Objective To analyze the incidence and mortality rates of corpus uteri cancer in China using 2008−2012 data from the National Central Cancer Registry (NCCR) of China.
Xi Y   +5 more
europepmc   +2 more sources

Liquid Biopsy as a Tool for Differentiation of Leiomyomas and Sarcomas of Corpus Uteri. [PDF]

open access: yesInt J Mol Sci, 2019
Utilization of liquid biopsy in the management of cancerous diseases is becoming more attractive. This method can overcome typical limitations of tissue biopsies, especially invasiveness, no repeatability, and the inability to monitor responses to ...
Dvorská D   +5 more
europepmc   +2 more sources

Postdiagnostic use of antihypertensive medications and survival in colorectal, lung, corpus uteri, melanoma and kidney cancer patients with hypertension. [PDF]

open access: yesBMC Cancer
Arterial hypertension is one of the most frequent comorbidities in patients with cancer. Studies have indicated that drugs used to control hypertension may alter cancer patient survival; however, epidemiological findings for their impact on cancer ...
Everatt R   +6 more
europepmc   +2 more sources

Cancer of the corpus uteri: A 2025 update. [PDF]

open access: yesInt J Gynaecol Obstet
Endometrial cancer comprises a heterogeneous group of neoplasms. Its incidence is increasing, as is mortality from endometrial cancer. This article updates many aspects surrounding endometrial cancer, covering histopathology, staging, surgical and non ...
Koskas M   +6 more
europepmc   +2 more sources

Association Between Radiotherapy and Death From Cardiovascular Disease Among Patients With Cancer: A Large Population‐Based Cohort Study

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background This study aimed to investigate the association between radiotherapy for cancer and cardiovascular disease (CVD) deaths and evaluate the relative risk for CVD deaths in the general population and among patients with cancer treated with ...
Enrui Liu   +7 more
doaj   +1 more source

Setting the record straight—Correcting uterine cancer incidence and mortality in the Nordic countries by reallocation of unspecified cases

open access: yesActa Obstetricia et Gynecologica Scandinavica, 2022
Introduction The incidence of and mortality from cancers of the cervix uteri and corpus uteri are underestimated if the presence of uterine cancers, where the exact topography (site of origin) is not specified, is omitted.
Veli‐Matti Partanen   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy